https://www.cancernetwork.com/view/trevor-m-feinstein-md-examines-docetaxel-with-or-without-plinabulin-in-stage-iiib-iv-egfr-wild-type-nsclc
0
0
Trevor M. Feinstein, MD, Examines Docetaxel With or Without Plinabulin in Stage IIIB/IV EGFR Wild-Type NSCLC - Cancer Network
8/22/22 at 2:03pm
Organization
Cancernetwork.com
Author
Ariana Pelosci
51 words
0
Comments
Trevor M. Feinstein, MD, discussed the phase 3 DUBLIN-3 trial evaluating docetaxel with or without plinabulin for patients with EGFR wild-type stage IIIB/IV non–small cell lung cancer.
You are the first to view
Create an account or login to join the discussion